Male hormone replacement therapy, commonly called testosterone replacement therapy or TRT, is covered by most insurance plans, but only when you meet specific medical criteria. The key distinction insurers make is between a diagnosed medical condition causing low testosterone and age-related decline on its own. If your low testosterone stems from a recognized disorder of the testicles, pituitary gland, or brain, you have a strong chance of getting coverage. If your levels are simply dropping with age and you have no underlying condition, most plans will deny the claim.
What Insurance Companies Require for Approval
The FDA has approved testosterone products only for men who have low testosterone levels tied to an associated medical condition. That’s the baseline insurers work from. Examples of qualifying conditions include genetic problems affecting the testicles, damage from chemotherapy, or disorders of the hypothalamus and pituitary gland that disrupt testosterone production. Medicare’s coverage determination uses nearly identical language: treatment is “medically reasonable and necessary” for symptomatic hypogonadism that’s congenital or acquired due to a disorder of the testicles, pituitary, or brain.
Private insurers layer additional requirements on top of that medical diagnosis. A real-world example from Priority Health illustrates what many plans demand before approving coverage:
- Symptoms beyond just fatigue or low sex drive. You need clinical signs consistent with androgen deficiency. Requests based solely on fatigue or decreased libido with no other symptoms are typically not covered.
- Two low testosterone blood tests. Your serum total testosterone must come in at 300 ng/dL or below on two separate dates within the previous 12 months. Lab results must be submitted with the request.
- Prior authorization. Most plans require your doctor to get approval before prescribing, submitting documentation that all criteria have been met.
The 300 ng/dL threshold is widely used across private insurers, though some plans set it slightly higher or lower. Your doctor will order morning blood draws, since testosterone peaks early in the day, and two separate low readings are standard before any insurer will consider the claim.
Which Delivery Methods Cost the Least
How you take testosterone makes a big difference in what you’ll pay out of pocket. Insurers use formulary tiers and step therapy requirements that strongly favor cheaper options first.
Generic injectable testosterone (testosterone cypionate and testosterone enanthate) sits at the bottom of the cost ladder. Many plans cover these injections without prior authorization at all. They’re the default starting point, and insurers expect you to try them before moving to anything else.
Topical gels, patches, and newer delivery methods like auto-injectors generally require prior authorization and sit on higher formulary tiers, meaning larger copays. The VA system, for example, classifies testosterone gel as requiring local prior authorization. To get a gel or patch covered, most plans require you to first try injectable testosterone for at least two months and either fail to improve or experience a genuine medical intolerance. “Needle phobia” or “needle fatigue” does not count as intolerance or a contraindication to injections in the eyes of most insurers.
If you do fail on injections, the next step is usually a generic topical testosterone. Brand-name gels and non-preferred products require yet another step: you’ll need to show that the generic topical also failed to improve your symptoms or raise your testosterone above 300 ng/dL after a minimum two-month trial.
Medicare Coverage
Medicare covers testosterone therapy under the same medical necessity framework as private insurance. The treatment must be for symptomatic hypogonadism caused by a documented medical condition. Medicare’s local coverage determination lists dozens of qualifying diagnosis codes, including hypopituitarism, benign tumors of the pituitary gland, and various forms of testicular failure.
What Medicare does not cover is testosterone prescribed purely for age-related decline in levels. The distinction matters because testosterone naturally drops about 1% per year after age 30, and many men in their 50s and 60s have levels below 300 ng/dL without any underlying disease. If your doctor can’t tie your low levels to a specific condition, Medicare will deny the claim regardless of your symptoms.
Medicare Part D covers the prescription medications themselves, while Part B may cover injectable testosterone administered in a doctor’s office. Your out-of-pocket costs depend on your specific Part D plan’s formulary and which tier testosterone falls on.
Why Claims Get Denied
The most common denial reasons follow a predictable pattern. Your testosterone level wasn’t documented as low enough on two separate tests. Your symptoms weren’t considered sufficient. You don’t have a qualifying underlying diagnosis. Or you’re requesting a more expensive delivery method without first trying and failing on a cheaper one.
That last category is surprisingly common. In one Michigan insurance case, a patient had been successfully using testosterone injections since 2013 and requested coverage for a topical gel instead. The insurer denied it specifically because the injections were working. The logic: if your current treatment is effective, there’s no medical basis to approve a more expensive alternative.
Another frequent issue is requesting TRT for symptoms alone without the blood work to back it up. Feeling tired, gaining weight, and having low energy are symptoms that overlap with dozens of other conditions. Without two separate lab results showing total testosterone at or below the insurer’s threshold, your claim will almost certainly be rejected.
How to Appeal a Denial
If your claim is denied, you have the right to appeal through your insurer’s internal grievance process. The most effective appeals include updated documentation: recent lab results showing your testosterone levels, a letter from your prescribing doctor explaining the medical necessity, and evidence that you’ve met all the plan’s criteria, including any step therapy requirements.
If the internal appeal fails, most states allow you to request an external independent review. This takes the decision out of the insurer’s hands and puts it before a third-party reviewer. In the Michigan case mentioned above, the patient escalated through both the internal grievance process and an external review under the state’s Patient’s Right to Independent Review Act.
Your chances improve significantly if your doctor clearly documents a qualifying diagnosis code, not just “low testosterone.” Codes for conditions like hypopituitarism or testicular failure carry far more weight with insurers than a general note about low levels. Ask your doctor which diagnosis code they’re submitting and whether it aligns with the codes your plan recognizes for coverage.
Paying Out of Pocket
If insurance won’t cover your TRT, or if you don’t have a qualifying diagnosis, the cost varies dramatically by delivery method. Generic testosterone cypionate injections can run as low as $30 to $50 per month without insurance at many pharmacies. Brand-name gels and patches can cost $200 to $500 or more monthly without coverage. Pellet implants, inserted under the skin every few months, typically range from $300 to $900 per session and are rarely covered even with insurance.
Some men turn to telehealth TRT clinics that operate outside the traditional insurance model entirely. These clinics charge monthly membership fees that bundle the prescription, lab monitoring, and sometimes the medication itself. While convenient, these services bypass the insurance system altogether, so you’re paying the full cost. If you do have insurance that would cover TRT with proper documentation, it’s worth working with your primary care doctor or an endocrinologist to pursue the covered route first.